The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Wearable Injector Devices Market Research Report 2025
Synopsis
Wearable injectors (WIs) are delivery systems that adhere to the body to administer larger volumes (more than 2 mL) of drug subcutaneously over an extended period.
The global Wearable Injector Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Wearable Injector Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Wearable Injector Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Wearable Injector Devices include SteadyMed Therapeutics, Inc., UNILIFE CORPORATION, Sensile Medical AGInsulet Corporation, Enable Injections, Becton, West Pharmaceutical Services, Inc., Ypsomed, Amgen and Buhler Motor GmbH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Wearable Injector Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Injector Devices.
Report Scope
The Wearable Injector Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wearable Injector Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Injector Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SteadyMed Therapeutics, Inc.
UNILIFE CORPORATION
Sensile Medical AGInsulet Corporation
Enable Injections
Becton
West Pharmaceutical Services, Inc.
Ypsomed
Amgen
Buhler Motor GmbH
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.
CeQur SA.
Segment by Type
Disposable
Reusable
Segment by Application
Oncology
Diabetes
Cardiovascular Diseases
Autoimmune Disorder
Infectious Diseases
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Injector Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Injector Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Wearable injectors (WIs) are delivery systems that adhere to the body to administer larger volumes (more than 2 mL) of drug subcutaneously over an extended period.
The global Wearable Injector Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Wearable Injector Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Wearable Injector Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Wearable Injector Devices include SteadyMed Therapeutics, Inc., UNILIFE CORPORATION, Sensile Medical AGInsulet Corporation, Enable Injections, Becton, West Pharmaceutical Services, Inc., Ypsomed, Amgen and Buhler Motor GmbH, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Wearable Injector Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Injector Devices.
Report Scope
The Wearable Injector Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Wearable Injector Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Injector Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
SteadyMed Therapeutics, Inc.
UNILIFE CORPORATION
Sensile Medical AGInsulet Corporation
Enable Injections
Becton
West Pharmaceutical Services, Inc.
Ypsomed
Amgen
Buhler Motor GmbH
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.
CeQur SA.
Segment by Type
Disposable
Reusable
Segment by Application
Oncology
Diabetes
Cardiovascular Diseases
Autoimmune Disorder
Infectious Diseases
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Injector Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Injector Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Wearable Injector Devices Market Overview
1.1 Product Overview and Scope of Wearable Injector Devices
1.2 Wearable Injector Devices Segment by Type
1.2.1 Global Wearable Injector Devices Market Value Comparison by Type (2024-2030)
1.2.2 Disposable
1.2.3 Reusable
1.3 Wearable Injector Devices Segment by Application
1.3.1 Global Wearable Injector Devices Market Value by Application: (2024-2030)
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Autoimmune Disorder
1.3.6 Infectious Diseases
1.3.7 Others
1.4 Global Wearable Injector Devices Market Size Estimates and Forecasts
1.4.1 Global Wearable Injector Devices Revenue 2019-2030
1.4.2 Global Wearable Injector Devices Sales 2019-2030
1.4.3 Global Wearable Injector Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Wearable Injector Devices Market Competition by Manufacturers
2.1 Global Wearable Injector Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Wearable Injector Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Wearable Injector Devices Average Price by Manufacturers (2019-2024)
2.4 Global Wearable Injector Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Wearable Injector Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Injector Devices, Product Type & Application
2.7 Wearable Injector Devices Market Competitive Situation and Trends
2.7.1 Wearable Injector Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Wearable Injector Devices Players Market Share by Revenue
2.7.3 Global Wearable Injector Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Wearable Injector Devices Retrospective Market Scenario by Region
3.1 Global Wearable Injector Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Wearable Injector Devices Global Wearable Injector Devices Sales by Region: 2019-2030
3.2.1 Global Wearable Injector Devices Sales by Region: 2019-2024
3.2.2 Global Wearable Injector Devices Sales by Region: 2025-2030
3.3 Global Wearable Injector Devices Global Wearable Injector Devices Revenue by Region: 2019-2030
3.3.1 Global Wearable Injector Devices Revenue by Region: 2019-2024
3.3.2 Global Wearable Injector Devices Revenue by Region: 2025-2030
3.4 North America Wearable Injector Devices Market Facts & Figures by Country
3.4.1 North America Wearable Injector Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Wearable Injector Devices Sales by Country (2019-2030)
3.4.3 North America Wearable Injector Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Wearable Injector Devices Market Facts & Figures by Country
3.5.1 Europe Wearable Injector Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Wearable Injector Devices Sales by Country (2019-2030)
3.5.3 Europe Wearable Injector Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Injector Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Wearable Injector Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Wearable Injector Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Wearable Injector Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Wearable Injector Devices Market Facts & Figures by Country
3.7.1 Latin America Wearable Injector Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Wearable Injector Devices Sales by Country (2019-2030)
3.7.3 Latin America Wearable Injector Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Injector Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Injector Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Wearable Injector Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Wearable Injector Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Wearable Injector Devices Sales by Type (2019-2030)
4.1.1 Global Wearable Injector Devices Sales by Type (2019-2024)
4.1.2 Global Wearable Injector Devices Sales by Type (2025-2030)
4.1.3 Global Wearable Injector Devices Sales Market Share by Type (2019-2030)
4.2 Global Wearable Injector Devices Revenue by Type (2019-2030)
4.2.1 Global Wearable Injector Devices Revenue by Type (2019-2024)
4.2.2 Global Wearable Injector Devices Revenue by Type (2025-2030)
4.2.3 Global Wearable Injector Devices Revenue Market Share by Type (2019-2030)
4.3 Global Wearable Injector Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Wearable Injector Devices Sales by Application (2019-2030)
5.1.1 Global Wearable Injector Devices Sales by Application (2019-2024)
5.1.2 Global Wearable Injector Devices Sales by Application (2025-2030)
5.1.3 Global Wearable Injector Devices Sales Market Share by Application (2019-2030)
5.2 Global Wearable Injector Devices Revenue by Application (2019-2030)
5.2.1 Global Wearable Injector Devices Revenue by Application (2019-2024)
5.2.2 Global Wearable Injector Devices Revenue by Application (2025-2030)
5.2.3 Global Wearable Injector Devices Revenue Market Share by Application (2019-2030)
5.3 Global Wearable Injector Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 SteadyMed Therapeutics, Inc.
6.1.1 SteadyMed Therapeutics, Inc. Corporation Information
6.1.2 SteadyMed Therapeutics, Inc. Description and Business Overview
6.1.3 SteadyMed Therapeutics, Inc. Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 SteadyMed Therapeutics, Inc. Wearable Injector Devices Product Portfolio
6.1.5 SteadyMed Therapeutics, Inc. Recent Developments/Updates
6.2 UNILIFE CORPORATION
6.2.1 UNILIFE CORPORATION Corporation Information
6.2.2 UNILIFE CORPORATION Description and Business Overview
6.2.3 UNILIFE CORPORATION Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 UNILIFE CORPORATION Wearable Injector Devices Product Portfolio
6.2.5 UNILIFE CORPORATION Recent Developments/Updates
6.3 Sensile Medical AGInsulet Corporation
6.3.1 Sensile Medical AGInsulet Corporation Corporation Information
6.3.2 Sensile Medical AGInsulet Corporation Description and Business Overview
6.3.3 Sensile Medical AGInsulet Corporation Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sensile Medical AGInsulet Corporation Wearable Injector Devices Product Portfolio
6.3.5 Sensile Medical AGInsulet Corporation Recent Developments/Updates
6.4 Enable Injections
6.4.1 Enable Injections Corporation Information
6.4.2 Enable Injections Description and Business Overview
6.4.3 Enable Injections Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Enable Injections Wearable Injector Devices Product Portfolio
6.4.5 Enable Injections Recent Developments/Updates
6.5 Becton
6.5.1 Becton Corporation Information
6.5.2 Becton Description and Business Overview
6.5.3 Becton Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Becton Wearable Injector Devices Product Portfolio
6.5.5 Becton Recent Developments/Updates
6.6 West Pharmaceutical Services, Inc.
6.6.1 West Pharmaceutical Services, Inc. Corporation Information
6.6.2 West Pharmaceutical Services, Inc. Description and Business Overview
6.6.3 West Pharmaceutical Services, Inc. Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 West Pharmaceutical Services, Inc. Wearable Injector Devices Product Portfolio
6.6.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
6.7 Ypsomed
6.6.1 Ypsomed Corporation Information
6.6.2 Ypsomed Description and Business Overview
6.6.3 Ypsomed Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ypsomed Wearable Injector Devices Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Corporation Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amgen Wearable Injector Devices Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Buhler Motor GmbH
6.9.1 Buhler Motor GmbH Corporation Information
6.9.2 Buhler Motor GmbH Description and Business Overview
6.9.3 Buhler Motor GmbH Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Buhler Motor GmbH Wearable Injector Devices Product Portfolio
6.9.5 Buhler Motor GmbH Recent Developments/Updates
6.10 F. Hoffmann-La Roche Ltd
6.10.1 F. Hoffmann-La Roche Ltd Corporation Information
6.10.2 F. Hoffmann-La Roche Ltd Description and Business Overview
6.10.3 F. Hoffmann-La Roche Ltd Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 F. Hoffmann-La Roche Ltd Wearable Injector Devices Product Portfolio
6.10.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
6.11 Johnson & Johnson Services, Inc.
6.11.1 Johnson & Johnson Services, Inc. Corporation Information
6.11.2 Johnson & Johnson Services, Inc. Wearable Injector Devices Description and Business Overview
6.11.3 Johnson & Johnson Services, Inc. Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Johnson & Johnson Services, Inc. Wearable Injector Devices Product Portfolio
6.11.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
6.12 CeQur SA.
6.12.1 CeQur SA. Corporation Information
6.12.2 CeQur SA. Wearable Injector Devices Description and Business Overview
6.12.3 CeQur SA. Wearable Injector Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CeQur SA. Wearable Injector Devices Product Portfolio
6.12.5 CeQur SA. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Injector Devices Industry Chain Analysis
7.2 Wearable Injector Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Injector Devices Production Mode & Process
7.4 Wearable Injector Devices Sales and Marketing
7.4.1 Wearable Injector Devices Sales Channels
7.4.2 Wearable Injector Devices Distributors
7.5 Wearable Injector Devices Customers
8 Wearable Injector Devices Market Dynamics
8.1 Wearable Injector Devices Industry Trends
8.2 Wearable Injector Devices Market Drivers
8.3 Wearable Injector Devices Market Challenges
8.4 Wearable Injector Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
